Our studies demonstrate that BRCA1 protein expression is required for the IR-induced activation of ERK1/2 signaling in breast cancer cells, and conversely, ERK1/2 activity supports the protein stability of BRCA1 in the irradiated breast cancer cells [72]. The gene discussed is MAPK3; the disease is breast carcinoma.